• TULIP: Anifrolumab exhibits 'many more pluses than minuses' in lupus

    25 days ago - By Healio

    After decades of research advances and reverses, blocking the interferon receptor in lupus may finally be showing consistent clinical benefit, according to a presentation at the United Rheumatology Spring Virtual conference.
    “Interferon has been hot for a couple of decades now in lupus,” Richard Furie, MD, chief of the division of rheumatology at Northwell Health, and professor of medicine at Hofstra/Northwell School of Medicine in New York. “The majority of lupus patients are interferon gene signature positive.”
    Furie suggested that lupus begins with genetic
    Read more ...